Greenspring Associates’s Zepp Health ZEPP Stock Holding History

Greenspring Associates’s Portfolio ZEPP Stock Details ZEPP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-861	Closed	-$45K	–	14
2019 Q1	$45K	Buy	+861	New	+$46.5K	0.02%	11

Other funds holding ZEPP

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Greenspring Associates's ZEPP Position: Q2 2019 in Review

Greenspring Associates sold out of Zepp Health (ZEPP) in Q2 2019, closing a stake of 861 shares — an estimated $45K sold.

Greenspring Associates first reported a position in ZEPP in Q1 2019 and held it in 1 quarter. The position peaked at $45K in Q1 2019. 40 funds tracked by Wall St. Rank hold ZEPP as of Q2 2019.

Greenspring Associates reported no remaining Zepp Health position as of Q2 2019 after selling out during the quarter.
Greenspring Associates sold 861 Zepp Health shares in Q2 2019, an estimated $45K.
Greenspring Associates first reported a position in Zepp Health in Q1 2019 and held it in 1 quarter.
Greenspring Associates's Zepp Health position peaked at $45K in Q1 2019.
40 funds tracked by Wall St. Rank held Zepp Health as of Q2 2019.

Based on Greenspring Associates's 13F filing for Q2 2019, filed 14 Feb 2020.